TARDBP and amyotrophic lateral sclerosis: Using pupal lethality as a readout of TDP-43 toxicity, an innovative drug screen for ALS suppressors identified pioglitazone, a PPARγ agonist, as a compound that mitigates TDP-43-dependent locomotor dysfunction (Joardar et al., 2015).